FMC to build microcrystalline cellulose facility in Thailand


FMC Corporation is planning to invest more than $100m to build a new microcrystalline cellulose (MCC) manufacturing plant in Rayong, Thailand.

"The facility's design will allow manufacturing of different product lines, both for the food and pharmaceutical markets."

The proposed facility initially will manufacture Avicel colloidal MCC, a food and beverages ingredient, and will increase FMC's global food grade MCC capacity by 35%.

Pierre Brondeau, FMC president, CEO and chairman, said the plant represents another major step in FMC's Vision 2015 growth strategy.

"This significant investment underscores FMC's continuing commitment to profitably grow our signature product lines, and to introduce or broaden the availability of leading FMC technologies in rapidly growing regions," Brondeau added.

The facility's design will allow manufacturing of different product lines, both for the food and pharmaceutical markets along with Avicel collodal production.

Michael Wilson, FMC Specialty Chemicals Group president, said demand for MCC continues to grow rapidly in Asia.

"This addition of significant new capacity to our MCC network will be needed to supply high-quality products and service to our Asian customers, while at the same time providing us with greater flexibility to support global growth with our existing capacity in North America and Europe," Wilson added.

The Rayong facility is expected to come on stream in the fourth quarter of 2014.